Acceptance and Quality Control Tests for the Single Photon Emission Computerized Tomography (SPECT) Gamma Cameras and SPECT/CT Systems
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 2
Abstract
Scintigraphic images play an important role in the diagnosis of diseases by providing accurate clinical information independent of the operator. However, the good quality image may not be obtained due to changes in the performance of the imaging system and/or external factors. A poor quality image will make difficult to interpretate clinical studies. Quality Control (QC) tests provide to reveal the conditions that will adversely affect the image quality before starting of scintigraphic imaging, and to make the necessary arrangements. Although QC tests show relative changes depending on the brand and model of gama camera, there are tests that must be done routinely. For gamma cameras [planar and single photon emission computerized tomography (SPECT)] to be newly installed in the Nuclear Medicine Clinic, “Acceptance Tests” should be carried out after the installation. “Checks before clinical studies” before starting daily scintigraphic studies, and routine QC studies at certain periods (weekly, monthly) should be performed. Standard measurement techniques, the most common test National Electrical Manufacturers Association (NEMA) method, should be used to ensure reliable results. NEMA NU 1-2018 Gamma Cameras’ Performance Measurements which provides a uniform and consistent method for measuring and reporting the performance parameters of SPECT scanners include updates for SPECT/computerized tomography (CT) systems. Updates of detector characterization and image quality measurements for detectors were made in accordance with iterative reconstruction. This update also includes QC tests for the interoperability of the CT and SPECT components of hybrid SPECT/CT systems. QC and acceptance tests of the systems with semisolid detectors (CZT crystals, etc) seen more frequent recently should be made according to this newly published document. The purpose of this guideline is to identify and facilitate the necessary acceptance and reference tests, routine QC applications on planar and SPECT gamma cameras, and SPECT/CT systems.
Authors and Affiliations
Semra Dönmez, Aslı Ayan, Yasemin Parlak, Bilal Kovan, Meral Hiçürkmez, F. Suna Kıraç, Mustafa Demir, Türkay Toklu, Tuğba Hacıosmanoğlu, İnci Alıç Özaslan, Leyla Poyraz
Keywords
Related Articles
- EP ID EP688740
- DOI 10.4274/nts.galenos.2020.0007
- Views 194
- Downloads 0
Guideline for PET/CT Imaging of Neuroendocrine Neoplasms with 68Ga-DOTA-conjugated Somatostatin Receptor Targeting Peptides
Neuroendocrine tumors (NETs) are one of the rare cancers that have been increasing in recent years. The importance of Ga-68 DOTA-Conjugated Peptides Receptor imaging has been reported in many retrospective and prospectiv...
Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals
As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a...
Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as...
Renal Transplant Scintigraphy
Renal transplantation, which is the best treatment for end-stage renal failure, increases the life expectancy and provides a better quality of life when compared to dialysis. Scintigraphy is a non-invasive, frequently re...
Should the Place of Radioactive Iodine Whole Body Scintigraphy in Follow-up of Differentiated Thyroid Cancer Reevaluated in the Era of SPECT/CT?
Radioactive iodine scan is a quite specific method used for many years in differentiated thyroid cancer (DTC). However, combination of neck ultrasonography and serum thyroglobulin and anti-thyroglobulin has a high sensit...